My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, ...

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...

This study fills a crucial gap in our understanding of blood cell formation from human pluripotent stem cells (hPSCs). Genome-wide comparisons of hPSC-derived blood progenitor cells with in vivo blood ...

Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.05%, which has investors questioning if this is right time to ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...